PubRank

G D Marshall

Author PubWeight™ 42.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 12.35
2 Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987 3.48
3 Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012 2.17
4 HIV-associated diarrhoea and wasting. Lancet 1995 1.41
5 Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy 2010 1.24
6 Smoking cessation for substance abuse inpatients. J Subst Abuse 1991 1.15
7 Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology 1996 1.04
8 Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J Interferon Cytokine Res 1998 1.03
9 Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Ann N Y Acad Sci 1979 1.00
10 Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001 0.98
11 Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol 2012 0.96
12 Stress effects on immunity and its application to clinical immunology. Clin Exp Allergy 2001 0.94
13 Beta-adrenergic modulation of human type-1/type-2 cytokine balance. J Allergy Clin Immunol 2000 0.92
14 Heart rate changes in pain and hypnosis. Psychophysiology 1974 0.88
15 The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans. J Burn Care Rehabil 1997 0.88
16 Planning recruitment. Circulation 1982 0.87
17 Role of CD28/B7 costimulation in the dexamethasone-induced suppression of IFN-gamma. J Interferon Cytokine Res 2000 0.85
18 Cooperative effects of corticosteroids and catecholamines upon immune deviation of the type-1/type-2 cytokine balance in favor of type-2 expression in human peripheral blood mononuclear cells. Brain Behav Immun 2007 0.84
19 In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. Hum Immunol 1998 0.82
20 In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice. J Immunol 1981 0.81
21 Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis. Mult Scler 1997 0.80
22 DNA repair capacity in healthy medical students during and after exam stress. J Behav Med 2000 0.80
23 Perimenstrual alterations in type-1/type-2 cytokine balance of normal women. Ann Allergy Asthma Immunol 1999 0.80
24 60  dB high-extinction auto-configured Mach-Zehnder interferometer. Opt Lett 2016 0.80
25 Silica and PM1648 modify human alveolar macrophage antigen-presenting cell activity in vitro. J Environ Pathol Toxicol Oncol 2001 0.79
26 Quantum-correlated photon pair generation in chalcogenide As2S3 waveguides. Opt Express 2010 0.78
27 Distinct serum cytokines in AIDS-related skin diseases. Viral Immunol 1998 0.77
28 Optical fiber coupled light emitting diode based absorbance detector with a reflective flow cell. Talanta 1999 0.76
29 Glucocorticoid receptor BclI polymorphism associates with immunomodulatory response to stress hormone in human peripheral blood mononuclear cells. Int J Immunogenet 2012 0.75
30 Multiple cycles of constant infusion recombinant interleukin-2 in adoptive cellular therapy of metastatic renal carcinoma. Mol Biother 1989 0.75
31 Dusting off recombinant allergens. Nat Biotechnol 1997 0.75
32 Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis. Ann Neurol 1995 0.75
33 Long-acting bronchodilators for the control of asthma symptoms. Ann Allergy Asthma Immunol 2001 0.75
34 Regulation of in vitro generation of cell-mediated cytotoxicity. II. Characterization of thymosin-induced suppressor T cells. Immunopharmacology 1980 0.75
35 Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer. Recent Results Cancer Res 1980 0.75
36 A cognitive-behavioral therapeutic community for substance dependent and homeless veterans: treatment outcome. Addict Behav 1995 0.75
37 Study of the influence of femtosecond laser polarisation on direct writing of waveguides. Opt Express 2006 0.75
38 Increased fecal IgE among infants in a rural community of Egypt: an analysis of associated risk factors. J Trop Pediatr 2001 0.75
39 Regulation of in vitro generation of cell-mediated cytotoxicity. In vitro induction of suppressor T lymphocytes by thymosin. J Reticuloendothel Soc 1980 0.75
40 Overview of thymosin activity. Cancer Treat Rep 1978 0.75
41 Principles of biotherapy and its application to the treatment of disseminated renal cancer. Semin Surg Oncol 1988 0.75
42 Alterations in the mitogen responsiveness of lymphocytes from mice bearing Moloney sarcoma virus induced tumors. Immunol Commun 1977 0.75
43 Annealing dynamics of waveguide Bragg gratings: evidence of femtosecond laser induced colour centres. Opt Express 2010 0.75
44 Preparation and analysis of bifunctional immunoconjugates containing monoclonal antibodies OKT3 and BABR1. Cancer Immunol Immunother 1989 0.75
45 Overview of recruitment to the coronary primary prevention trial. Circulation 1982 0.75